Select status:
Sort by:
Filter by consultation end date

Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and December 2021

Filter by area of interest
Filter by type
Showing 1 to 10 of 14
Title Consultation Type Consultation end date
Type 2 diabetes in adults: management - SGLT2 inhibitors for chronic kidney disease (update) Draft guidance consultation NICE guideline Type:29 September 2021 20210929
Asthma: diagnosis, monitoring and chronic asthma management Draft scope consultation NICE guideline Type:30 September 2021 20210930
Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancer (CDF Review TA600) ID1683 Appraisal consultation Technology appraisal guidance Type:30 September 2021 20210930
Pernicious anaemia Draft scope consultation NICE guideline Type:06 October 2021 20211006
Otitis media with effusion in under 12s: surgery Draft scope consultation NICE guideline Type:06 October 2021 20211006
Odevixibat for treating progressive familial intrahepatic cholestasis [ID1570] Evaluation consultation: 1 Highly specialised technology Type:07 October 2021 20211007
GID-MT561 ClearGuard HD Antimicrobial Barrier Cap for preventing haemodialysis catheter-related bloodstream infections Draft guidance: 1 Medical technologies guidance Type:11 October 2021 20211011
Colorectal cancer (QS update) Quality standard consultation Quality standard Type:11 October 2021 20211011
Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma after stem cell transplant or at least 2 previous therapies [ID1557] Appraisal consultation Technology appraisal guidance Type:12 October 2021 20211012
Type 2 diabetes in adults: management (update) Draft guidance consultation NICE guideline Type:14 October 2021 20211014